Hemp in the United States: A Case Study of Regulatory Path Dependence

Trey Malone () and Kevin Gomez

Applied Economic Perspectives and Policy, 2019, vol. 41, issue 2, 199-214

Abstract: The Agricultural Act of 2014 allowed for federally funded research on hemp for the first time since 1937. Since 2014, pro‐hemp legislation has received increasingly bipartisan support, culminating with the Hemp Farming Act of 2018, which would remove industrial hemp from its current listing as a Schedule 1 drug, and allow hemp to be treated like any other agricultural commodity. In part because of this legalization, hemp production in the United States has the potential to increase substantially. This study describes what is known about the economic and regulatory considerations of U.S. hemp agriculture through the lens of path dependency. Important questions remain regarding the legal and regulatory landscape of hemp, and are further complicated by its current listing as a Schedule 1 drug.

Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (9)

Downloads: (external link)
https://doi.org/10.1093/aepp/ppz001

Related works:
Working Paper: Hemp in the United States: A Case Study of Regulatory Path Dependency (2018)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:apecpp:v:41:y:2019:i:2:p:199-214

Access Statistics for this article

More articles in Applied Economic Perspectives and Policy from John Wiley & Sons
Bibliographic data for series maintained by Wiley Content Delivery ().